Skip to main content

Levobupivacaine

ADVERTISEMENT
Identification
Molecular formula
C18H28N2O2
CAS number
27262-48-2
IUPAC name
propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate
State
State

At room temperature, Levobupivacaine is in a solid state, specifically as a crystalline powder. It maintains this solid form unless subjected to conditions above its melting point.

Melting point (Celsius)
116.00
Melting point (Kelvin)
389.15
Boiling point (Celsius)
286.00
Boiling point (Kelvin)
559.15
General information
Molecular weight
324.47g/mol
Molar mass
324.4710g/mol
Density
0.9280g/cm3
Appearence

Levobupivacaine typically appears as a white to off-white crystalline powder. It is odorless and is known for being soluble in water and alcohols. The appearance can also be described as a dry solid at room temperature.

Comment on solubility

Solubility of Propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate

The solubility of propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate is influenced by several key factors:

  • Polarity: The presence of both hydrophobic (cyclohexyl and propyl groups) and hydrophilic (amino and acetamido groups) components in the structure affects its overall polarity. As a result, its solubility can vary significantly in different solvents.
  • Temperature: Like many organic compounds, an increase in temperature can enhance solubility. Therefore, evaluating its solubility at different temperatures may yield interesting insights.
  • Solvent Type: This compound likely exhibits better solubility in organic solvents (like alcohols or ethers) than in aqueous solutions due to its relatively non-polar regions.
  • Functional Groups: The amino groups may enable hydrogen bonding with polar solvents, potentially increasing solubility under certain conditions.

In summary, the solubility of propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate can be described as moderate to variable, primarily depending on solvent environment and temperature. Experimental investigations are essential to accurately determine its solubility profile.

Interesting facts

Interesting Facts about Propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate

Propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate is a fascinating compound that belongs to the class of benzoate esters. It possesses unique structural features that contribute to its potential applications in various fields, particularly in medicinal chemistry.

Key Highlights:

  • Pharmacological Potential: Compounds similar to this one have shown promise in pharmaceutical research, particularly as they may exhibit anti-inflammatory and analgesic properties.
  • Structural Diversity: The presence of both cyclohexylamine and a 3,5-dimethyl substitution pattern on the benzoate ring enhances the structural diversity, providing opportunities for the development of novel therapeutic agents.
  • Applications: This compound's unique combination of functional groups makes it a candidate for drug design, potentially leading to effective treatments for diseases associated with pain and inflammation.
  • Chemical Synthesis: The synthesis of propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate involves multiple steps and requires careful manipulation of reagents to achieve the desired purity and yield.

As a compound that integrates elements from both organic chemistry and pharmacology, propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate exemplifies the importance of structure-activity relationships in drug discovery. Understanding how variations in molecular structure can influence biological activity is crucial for researchers looking to innovate in the world of medicinal chemistry.

In conclusion, the study of compounds like this allows scientists to push the boundaries of current pharmaceutical knowledge and explore new therapeutic avenues, potentially leading to breakthroughs in drug development.

Synonyms
BRN 2396651
BENZOIC ACID, 4-(2-(CYCLOHEXYLAMINO)ACETAMIDO)-3,5-DIMETHYL-, PROPYL ESTER
3095-40-7
DTXSID30184923
4-(2-(Cyclohexylamino)acetamido)-3,5-dimethylbenzoic acid propyl ester
DTXCID70107414